🔎 Trials Near Me

Utama › Kanser Paru-paru › Wisconsin › Madison

Kajian klinikal Kanser Paru-paru di Madison, WI

10 kajian untuk Kanser Paru-paru sedang mencari peserta di lokasi dalam dan sekitar Madison (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Mengambil pesertaFasa 3
  • William S Middleton VA Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT04267848

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Mengambil pesertaFasa 1/2
  • University of Wisconsin Carbone Cancer Center, Madison
Umur 12 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT04585750

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • William S Middleton VA Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Mengambil pesertaFasa 1
  • Wisconsin Institute for Medical Research, Madison
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06625775

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Mengambil pesertaFasa 3
  • SSM Health Dean Medical Group - South Madison Campus Health Research/Circuit Clinical, Madison
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT06119581

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Mengambil pesertaFasa 3
  • William S Middleton VA Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT05624996

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • University of Wisconsin- Madison, Madison
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT05592626

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Mengambil pesertaFasa 2/3
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Mei 2026 · NCT06616584

Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer

Mengambil pesertaFasa 2
  • University of Wisconsin, Madison
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Apr 2026 · NCT04919382

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

Mengambil pesertaFasa 2
  • University of Wisconsin, Madison
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Jun 2025 · NCT03175224

Kajian Kanser Paru-paru di bandar lain

Kajian lain di Madison

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.